Skip to main content
. 2020 Feb 8;20:73–85. doi: 10.1016/j.omtn.2020.01.036

Table 2.

Blood Parameter Changes

Day 19
Day 43
Vehicle ± SD 125 mg/kg/day ± SD Vehicle ± SD 125 mg/kg/day ± SD
Hematologic Parameter

NeutroHephil 0.95 ± 0.443* F 0.37 ± 0.08 F 1.81 ± 0.567 M 0.76 ± 0.057 M
Reticulocytes 2.88 ± 0.997** F 1.46 ± 0.219 F 2.39 ± 0.656 F 1.39 ± 0.354 F
Monocytes 0.55 ± 0.186 M 0.14 ± 0.028 M
LUC 0.19 ± 0.07 M0.11 ± 0.05 F 0.08 ± 0.00 M0.04 ± 0.00 F
Eosinophils 0.08 ± 0.032 0.14 ± 0.045

Biochemistry Parameter

Creatinine 22.32 ± 0.980 M26.62 ± 0.972 F 35.58 ± 5.109 M31.26 ± 1.547 F 28.40 ± 1.563 M 35.58 ± 1.450 M
Urea 4.5 ± 0.68 M4.9 ± 0.40 F 7.2 ± 1.77 M6.4 ± 0. 61 F 4.5 ± 0.52 M4.7 ± 0.38 F 6.9 ± 0.71 M7.1 ± 1.27 F
Glucose 5.76 ± 0.534 M 7.75 ± 1.041** M 6.16 ± 0.855M6.42 ± 0.255 F 8.74 ± 0.184M8.69 ± 1.57 F
Triglyceride 0.51 ± 0.151 M 0.21 ± 0.037* M 0.82 ± 0.339 M 0.18 ± 0.071 M
ALAT 39 ± 4.3 M 59 ± 6.4* M 47 ± 10.2 M 34 ± 3.5 M

Blood parameter changes were observed at the end of the treatment period (day 19, n = 5/sex/group) and at the end of the recovery period (day 43, n = 3/sex/group) as measured in the animal group treated with 125 mg/kg/day of LNA-i-miR-221 or in the control (vehicle) group. M, male; F, female. *p < 0.01, **p < 0.05.